Cargando…
CTBP1 and metabolic syndrome induce an mRNA and miRNA expression profile critical for breast cancer progression and metastasis
Metastatic breast cancer (BrCa) is still one of the main causes of cancer death in women. Metabolic syndrome (MeS), a risk factor for BrCa, is associated to high grade tumors, increased metastasis and recurrence of this disease. C-terminal binding protein 1 (CTBP1) is a co-repressor of tumor suppres...
Autores principales: | Farré, Paula L., Scalise, Georgina D., Duca, Rocío B., Dalton, Guillermo N., Massillo, Cintia, Porretti, Juliana, Graña, Karen, Gardner, Kevin, De Luca, Paola, De Siervi, Adriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862620/ https://www.ncbi.nlm.nih.gov/pubmed/29568399 http://dx.doi.org/10.18632/oncotarget.24486 |
Ejemplares similares
-
CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice
por: Dalton, Guillermo Nicolás, et al.
Publicado: (2019) -
CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs
por: De Luca, Paola, et al.
Publicado: (2016) -
Adipose tissue from metabolic syndrome mice induces an aberrant miRNA signature highly relevant in prostate cancer development
por: Massillo, Cintia, et al.
Publicado: (2020) -
MiR-106b-5p: A Master Regulator of Potential Biomarkers for Breast Cancer Aggressiveness and Prognosis
por: Farré, Paula Lucía, et al.
Publicado: (2021) -
Hsa-miR-133a-3p, miR-1-3p, GOLPH3 and JUP combination results in a good biomarker to distinguish between prostate cancer and non-prostate cancer patients
por: Duca, Rocío Belén, et al.
Publicado: (2022)